KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Invested Capital: 2016-2025

Historic Invested Capital for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $9.4 billion.

  • Moderna's Invested Capital fell 25.39% to $9.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 billion, marking a year-over-year decrease of 25.39%. This contributed to the annual value of $11.0 billion for FY2024, which is 24.02% down from last year.
  • Per Moderna's latest filing, its Invested Capital stood at $9.4 billion for Q3 2025, which was down 0.75% from $9.5 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Invested Capital ranged from a high of $20.2 billion in Q4 2022 and a low of $4.0 billion during Q1 2021.
  • For the 3-year period, Moderna's Invested Capital averaged around $13.1 billion, with its median value being $12.6 billion (2024).
  • Per our database at Business Quant, Moderna's Invested Capital spiked by 453.17% in 2021 and then crashed by 32.52% in 2024.
  • Moderna's Invested Capital (Quarterly) stood at $14.9 billion in 2021, then spiked by 35.46% to $20.2 billion in 2022, then dropped by 28.56% to $14.4 billion in 2023, then decreased by 24.02% to $11.0 billion in 2024, then decreased by 25.39% to $9.4 billion in 2025.
  • Its Invested Capital was $9.4 billion in Q3 2025, compared to $9.5 billion in Q2 2025 and $10.1 billion in Q1 2025.